Jacqueline Walsh
About Jacqueline Walsh
Jacqueline Walsh is the Director of Regulatory CMC at Deciphera Pharmaceuticals, where she has worked since 2022. She has extensive experience in quality control and regulatory affairs, having held various positions at companies such as Merck, Takeda, and Shire.
Current Role at Deciphera Pharmaceuticals
Jacqueline Walsh currently serves as the Director of Regulatory CMC at Deciphera Pharmaceuticals. She has held this position since 2022, contributing to the company's regulatory strategies and compliance efforts in Waltham, Massachusetts. Her role involves overseeing the regulatory aspects of chemistry, manufacturing, and controls, ensuring that products meet the necessary standards for safety and efficacy.
Previous Experience in Regulatory CMC
Prior to her current role, Jacqueline Walsh worked at Deciphera Pharmaceuticals in various capacities, including Senior Manager and Associate Director of Regulatory CMC. Her experience spans from 2020 to 2022, during which she developed expertise in regulatory submissions and compliance. Additionally, she held the position of Senior Manager, Regulatory CMC at Takeda from 2019 to 2020, further enhancing her knowledge in the field.
Quality Control Experience
Jacqueline Walsh has a solid background in quality control, having worked as a Senior Specialist at Merck from 2015 to 2016 and as a Senior Analyst at Cubist Pharmaceuticals from 2010 to 2012. Her roles involved ensuring product quality and compliance with industry standards. She also served as a QC Manager at Cubist Pharmaceuticals from 2013 to 2015 and as Manager and Project Leader at Chemic Laboratories Inc. from 2007 to 2010.
Educational Background in Biochemistry and Molecular Biology
Jacqueline Walsh earned her Bachelor of Arts degree in Biochemistry and Molecular Biology from Boston University, where she studied from 1999 to 2003. This academic foundation provided her with essential knowledge and skills applicable to her career in pharmaceuticals and regulatory affairs.